Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy

Acta Haematologica

Volumn 116, Issue 4, 2006, Pages 259-265

  Bencaiova, Gabriela ^a,b   Krafft, Alexander ^a   Burkhardt, Tilo ^a   Breymann, Christian ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anemia; Erythropoietin, recombinant human; Hemoglobinopathy; Pregnancy; Resistance

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ALLERGIC REACTION; ANEMIA; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HETEROZYGOSITY; HUMAN; HYPERTENSION; LOW DRUG DOSE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINOPATHIES; HETEROZYGOTE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; TREATMENT OUTCOME;

EID: 33751268942     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095877     Document Type: Article

References (18)

1. Eldibany MM, Totonchi KF, Joseph NJ, Rhone D: Usefulness of certain red blood cell indices in diagnosing and differentiating thalassemia trait from iron-deficiency anemia. Am J Clin Pathol 1999;111:676-682.
2. Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R: Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. J Matern Fetal Med 1999;8:1-7.
3. Bennett M, Macri CJ, Bathgate SL: Erythropoietin use in a pregnant Jehovah's witness with anemia and beta-thalassemia: a case report. J Reprod Med 2005;50:135-137.
4. Junca J, Vela D, Orts M, Riutort N, Feliu E: Treating the anaemia of a pregnancy with heterozygous beta thalassaemia with recombinant human erythropoietin (r-HuEPO). Eur J Haematol 1995;55:277-278.
5. Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G: Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. Blood Purif 2004;22:453-460.
6. Krafft A, Breymann C: Haemoglobinopathy in pregnancy: diagnosis and treatment. Curr Med Chem 2004;11:2903-2909.
7. Rachmilewitz EA, Aker M: The role of recombinant human erythropoietin in the treatment of thalassemia. Ann NY Acad Sci 1998;850:129-138.
8. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA: Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16-19.
9. Cheng IKT, Lu HB, Wei DCC: Influence of thalassemia on the response to erythropoietin in dialysis patients. Am J Nephrol 1993;13:142-148.
10. Lai KN, Wung KC, Li PK, Lui SF: Use of recombinant erythropoietin in thalassaemic patients on dialysis. Am J Kidney Dis 1992;19:239-245.
11. Cozma G, Cozma MC, Mattes U: Beneficial effect of erythropoietin in beta thalassemia patients on dialysis. Nephrol Dial Transplant 1992;7:82-93.
12. CDC criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 1989;38:400-404.
13. Cazzola M, Mercuriali F, Brugnara C: Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997;89:4248-4267.
14. Schrier SL: Pathophysiology of thalassemia. Curr Opin Hematol 2002;9:123-126.
15. Lemsaddek W, Picanco I, Seuanes F, Mahmal L, Benchekroun S, Khattab M, Nogueira P, Osorio-Almeida L: Spectrum of beta thalassemia mutations and HbF levels in the heterozygous Moroccan population. Am J Hematol 2003;73:161-168.
16. Di Iorio B, Guastaferro P, Bellizzi V: Relationship between resistance to erythropoietin and high anomalous hemoglobin levels in hemodialysis patients with beta-thalassemia minor. Blood Purif 2003;21:376-380.
17. Rachmilewitz EA, Aker M, Perry D, Dover G: Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia. Br J Haematol 1995;90:341-345.
18. Schneider H, Malek A: Lack of permeability of the human placenta for erythropoietin. J Perinat Med 1995;23:71-76.